AAAAAA
Results:
1-8
|
Results: 8
Authors:
De Kerf, M
Mondelaers, W
Lahorte, P
Vervaet, C
Remon, JP
Citation: M. De Kerf et al., Characterisation and disintegration properties of irradiated starch, INT J PHARM, 221(1-2), 2001, pp. 69-76
Authors:
Vergote, GJ
Vervaet, C
Van Driessche, I
Hoste, S
De Smedt, S
Demeester, J
Jain, RA
Ruddy, S
Remon, JP
Citation: Gj. Vergote et al., An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen, INT J PHARM, 219(1-2), 2001, pp. 81-87
Authors:
Vervaet, C
Byron, PR
Citation: C. Vervaet et Pr. Byron, Polystyrene microsphere spray standards based on CFC-free inhaler technology, J AEROSOL M, 13(2), 2000, pp. 105-115
Authors:
Smet, E
Baeyens, WRG
Van der Weken, G
Kiekens, F
Vervaet, C
Remon, JP
Citation: E. Smet et al., A validated HPLC method for the determination of thiazinamium methylsulphate in pharmaceutical preparations, J PHARM B, 23(1), 2000, pp. 175-183
Authors:
De Brabander, C
Vervaet, C
Gortz, JP
Remon, JP
Berlo, JA
Citation: C. De Brabander et al., Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystalline wax, INT J PHARM, 208(1-2), 2000, pp. 81-86
Authors:
De Brabander, C
Vervaet, C
Fiermans, L
Remon, JP
Citation: C. De Brabander et al., Matrix mini-tablets based on starch/microcrystalline wax mixtures, INT J PHARM, 199(2), 2000, pp. 195-203
Authors:
Vervaet, C
Byron, PR
Citation: C. Vervaet et Pr. Byron, Drug-surfactant-propellant interactions in HFA-formulations, INT J PHARM, 186(1), 1999, pp. 13-30
Authors:
Voorspoels, J
D'Haese, E
de Craene, BA
Vervaet, C
de Riemaecker, D
Deprez, P
Nelis, H
Remon, JP
Citation: J. Voorspoels et al., Pharmacokinetics of florfenicol after treatment of pigs with single oral or intramuscular doses or with medicated feed for three days, VET REC, 145(14), 1999, pp. 397-399
Risultati:
1-8
|